CiteAb

Fig.2.E showing Western Blotting from the publication: ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer.

Fig.8.B showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.6.C showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.6.A showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.5.C showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.5.A showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.5.B showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.6.E showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Fig.2.F showing Western Blotting in a Homo sapiens (Human) sample from the publication: 27-Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer.

Fig.7.A showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner.

Fig.7.C showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner.

Fig.7.B showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner.

Fig.4.A showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner.

Fig.3.A showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Fig.3.B showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Fig.4.A showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Fig.4.F showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Fig.3.G showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Fig.5.A showing Western Blotting in a Homo sapiens (Human) sample from the publication: MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.

Fig.3.C showing Western Blotting from the publication: Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.

Fig.2.C showing Western Blotting from the publication: Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction.

Fig.2.D showing Western Blotting from the publication: Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction.

Fig.2.A showing Western Blotting from the publication: Mithramycin selectively attenuates DNA-damage-induced neuronal cell death.

Fig.1.C showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.

Fig.4.C showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.

70 images found

Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry.

In Nature on 1 October 2025 by Paul, D., Bolhuis, D. L., et al.

Mammalian cells entering the cell cycle favour glycolysis to rapidly generate ATP and produce the biosynthetic intermediates that are required for rapid biomass accumulation1. Simultaneously, the ubiquitin-ligase anaphase-promoting complex/cyclosome and its coactivator CDH1 (APC/CCDH1) remains active, allowing origin licensing and blocking premature DNA replication. Paradoxically, glycolysis is reduced by APC/CCDH1 through the degradation of key glycolytic enzymes2, raising the question of how cells coordinate these mutually exclusive events to ensure proper cell division. Here we show that cells resolve this paradox by transiently inactivating the APC/C during cell cycle entry, which allows a transient metabolic shift favouring glycolysis. After mitogen stimulation, rapid mTOR-mediated phosphorylation of the APC/C adapter protein CDH1 at the amino terminus causes it to partially dissociate from the APC/C. This partial inactivation of the APC/C leads to the accumulation of PFKFB3, a rate-limiting enzyme for glycolysis, promoting a metabolic shift towards glycolysis. Delayed accumulation of phosphatase activity later removes CDH1 phosphorylation, restoring full APC/C activity, and shifting cells back to favouring oxidative phosphorylation. Thus, cells coordinate the simultaneous demands of cell cycle progression and metabolism through an incoherent feedforward loop, which transiently inhibits APC/C activity to generate a pulse of glycolysis that is required for mammalian cell cycle entry.
© 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Show More

Senescent Microglia Mediate Neuroinflammation-Induced Cognitive Dysfunction by Selective Elimination of Excitatory Synapses in the Hippocampal CA1.

In Aging Cell on 1 September 2025 by Liu, K., Fan, D., et al.

Microglia-mediated neuroinflammation has been shown to exert an important effect on the progression of a growing number of neurodegenerative disorders. Prolonged exposure to detrimental stimuli leads to a state of progressive activation and aging-related features in microglia (also termed as senescent microglia). However, the mechanisms by which senescent microglia contribute to neuroinflammation-induced cognitive dysfunction remain to be elucidated. Here, we developed a mouse model of neuroinflammation induced by lipopolysaccharides at 0.5 mg/kg for 7 consecutive days. To evaluate cognitive function, C57BL/6J mice were employed and subjected to a series of behavioral assessments, including the open field, Y-maze, and novel object recognition tests. Employing single-cell RNA sequencing technology, we have delved into the differential expressions of RNA within microglia. Furthermore, to investigate anatomic and physiological alterations of pyramidal neurons, we utilized Golgi staining and whole-cell patch-clamp recordings, respectively. Validation of our results in protein expression was performed using western blotting and immunofluorescence. We specifically identified senescent microglia with a high expression of p16INK4a and observed that microglia in the hippocampal CA1 region of the model exhibited signatures of elevated phagocytosis and senescence. A senolytic by ABT-737 treatment alleviated the production of senescence-associated secretory phenotypes, the accumulation of senescent microglia, and the microglial hyperphagocytosis of excitatory synapses following LPS exposures. This treatment also restored reduced excitatory synaptic transmission, impaired long-term potentiation, and cognitive function in the model. These results indicate that reducing senescent microglia may potentially serve as a therapeutic approach to prevent neuroinflammation-related cognitive dysfunction.
© 2025 The Author(s). Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Show More

Resistance training suppresses accumulation of senescent fibro-adipogenic progenitors and senescence-associated secretory phenotype in aging rat skeletal muscle.

In GeroScience on 1 April 2025 by Hung, Y. L., Sato, A., et al.

Accumulation of senescent cells in tissues contributes to multiple aging-related pathologies. Senescent fibro-adipogenic progenitors (FAPs) contribute to aging-related muscle atrophy. Resistance training can help to maintain skeletal muscle mass, improve mobility, and reduce certain health risks commonly associated with aging. We investigated, using rat model, the impact of resistance training on FAPs in aging skeletal muscle, which remains unclear. Twenty-two-month-old female rats were divided into sedentary and training groups. The training group rodents were trained to climb a ladder while bearing a load for 20 training sessions over 2 months, after which, the flexor hallucis longus muscles were collected and analyzed. Senescent cells were identified using a senescence-associated β-galactosidase stain and p21 immunohistochemistry (IHC), and FAPs were identified using platelet-derived growth factor receptor alpha IHC. The results indicate that resistance training in rats prevented aging-associated skeletal muscle atrophy and suppressed M2 polarization of macrophages. The number of senescent cells was significantly reduced in the 24-month-old training group, with most of them being FAPs. Conversely, the number of senescent FAPs increased significantly in the 24-month-old sedentary group compared with that in the 18-month-old sedentary group. The number of senescent FAPs in the 24-month-old training group decreased significantly. Resistance training also suppressed the senescence-associated secretory phenotype (SASP). The killer T cell-specific marker, CD8α, was elevated in the skeletal muscles of the aging rats following resistance training, indicating upregulation of recognition and elimination of senescent cells. Overall, resistance training suppressed the accumulation of senescent FAPs and acquisition of SASP in aging skeletal muscles.
© 2024. The Author(s).

Show More

Improved Therapeutic Efficiency of Senescent Cell-specific, Galactose-Functionalized Micelle Nanocarriers.

In Small (Weinheim An Der Bergstrasse, Germany) on 1 February 2025 by Parshad, B., Baker, A. G., et al.

Cellular senescence has recently been recognized as one of the hallmarks of cancer, aging, as well as many age-related disorders, sparking significant interest in the development of senolytics, compounds that can remove senescent cells. However, most current pharmacological strategies face challenges related to non-specific delivery, leading to significant side effects that hinder safe and effective treatments. To address these issues, galactose-functionalized amphiphiles are synthesized that can self-assemble into micelles and be loaded with a senolytic cargo. These galactose-micelles are responsive to the lysosomal β-galactosidase enzyme, present in elevated amounts in senescent cells, and are employed for specific delivery of the senolytic Bcl2-inhibitor Navitoclax. This novel formulation showed reduced delivery and toxicity to non-senescent cells, thereby increasing the senolytic index of Navitoclax and making it suitable for future in vivo experimental designs to improve selectivity and safety profiles.
© 2024 The Author(s). Small published by Wiley‐VCH GmbH.

Show More

p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment.

In Cell Death & Disease on 26 January 2025 by Yanushko, D., German, B., et al.

Prostate cancer is a heterogeneous disease with a slow progression and a highly variable clinical outcome. The tumor suppressor genes PTEN and TP53 are frequently mutated in prostate cancer and are predictive of early metastatic dissemination and unfavorable patient outcomes. The progression of solid tumors to metastasis is often associated with increased cell plasticity, but the complex events underlying TP53-loss-induced disease aggressiveness remain incompletely understood. Using genetically engineered mice, we show that Trp53 deficiency in Pten-null prostatic epithelial cells (PECs) does not impact early cell proliferation and neoplasia formation, nor growth arrest and senescence entry at a later time. However, Trp53-deficiency enhances invasive adenocarcinoma development and promotes metastatic cell dissemination. Importantly, our single-cell transcriptomic and chromatin accessibility analyses combined with histological examinations uncovered an epithelial cell population characterized by an induction of Jak/Stat3 signaling and displaying mesenchymal features. Moreover, we show that the transcriptomic signature of this cell population is prominent in tumors of patients with high-risk prostate cancer or metastatic disease. In addition, our in vivo and organoid-based experiments provide evidence that PEC plasticity occurs through bi-directional communication with cancer-associated fibroblasts (CAFs). Thus, our study demonstrates that p53 loss induces a protumorigenic crosstalk between PECs and CAFs, and identifies new vulnerabilities that might be targeted to limit cancer progression.
© 2025. The Author(s).

Show More

View this product on CiteAb

ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer.

In EMBO Mol Med on 1 October 2024 by Pozzato, C., Outeiro-Pinho, G., et al.

Fig.2.E

Fig.2.E showing Western Blotting from the publication: ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer.

ERK5 and CDK5 synergistically promote FAK function.(A) Percentage of proliferation inhibition of A549, A427 and H460 cell lines treated with increasing doses of XMD8-92 or Seliciclib or in combination (top) 48 h after treatment and representative crystal violet-stained cells 72 h after drug treat... more

ERK5 and CDK5 synergistically promote FAK function.(A) Percentage of proliferation inhibition of A549, A427 and H460 cell lines treated with increasing doses of XMD8-92 or Seliciclib or in combination (top) 48 h after treatment and representative crystal violet-stained cells 72 h after drug treatment (bottom). The combination index (CI) showing the synergistic effect of combination of the 2 drugs is indicated; n = 3. (B–D) Relative quantification of Annexin V (AV) + Annexin V/PI (AV/PI)-positive cells by flow cytometry; n = 4 (B), colony forming capacity; n = 3 (C) and percentage of cell migration; n = 10 (D) of A549 cells treated with 10 µM XMD8-92 or Seliciclib or in combination, except for the colony formation assay in which cells were treated with 5 µM of each drug. (E) Immunoblot analysis of the indicated targets in A549 cells treated with the indicated doses of Seliciclib or XMD8-92 or in combination for 24 h. (F) Immunoblot analysis of the indicated targets in A549 cells treated with 10 µM XMD8-92 or 10 µM Seliciclib or in combination for 24 h. (G) Immunoblot analysis for the indicated targets in A549 cells transduced with shRNA control (pLKO.1 hygro + Tet-pLKO-puro) or a shRNA against CDK5 (Tet-pLKO-puro-shCDK5 + pLKO.1 hygro), or a shRNA against ERK5 (pLKO.1 hygro-shERK5 + Tet-pLKO-puro) or in combination (Tet-pLKO-puro-shCDK5 + pLKO.1 hygro-shERK5). After transduction and selection, cells were harvested for protein extraction 72 h after doxycycline (1 μg/mL) induction. (H, I) Relative cell number (H) and Annexin V (AV) + Annexin V/PI (AV/PI)-positive cell quantification by flow cytometry (I) in A549 cells treated as in (G) 72 h after doxycycline (1 μg/mL) induction; n = 3. Graphical data are mean ± SD. Statistical analyses were done using one-way ANOVA; n, number of biologically independent samples. Source data are available online for this figure. less

Collected and cropped from EMBO Molecular Medicine by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

In Cell Death Dis on 29 May 2024 by Neuwahl, J., Neumann, C. A., et al.

Fig.8.B

Fig.8.B showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

Primary senescent fibroblast and epithelial cells are resistant to PI3K-inhibitor-induced senolysis.A The immortalized primary fibroblast BJ/hTERT and epithelial RPE-340/hTERT cell lines were exposed to 20 Gy γIR and senescence induction was determined by staining for senescence-associated beta-g... more

Primary senescent fibroblast and epithelial cells are resistant to PI3K-inhibitor-induced senolysis.A The immortalized primary fibroblast BJ/hTERT and epithelial RPE-340/hTERT cell lines were exposed to 20 Gy γIR and senescence induction was determined by staining for senescence-associated beta-galactosidase activity at day 4 and day 7 following irradiation. Senescent cells display a strong blue color. Microscopic pictures were taken with the same 10x magnification (scale bar 100 µM in the lower right panel) and are representative of at least three independent experiments. B Western blot analyses of the expression of the indicated proteins in BJ/hTERT and RPE-340/hTERT cells at one, three and seven days after 20 Gy γIR. The blots shown are representative of at least three independent experiments. C, D Proliferating and senescent (day 7 after γIR) BJ/hTERT (C) and RPE-340/hTERT (D) cells were exposed to the indicated concentrations of the PI3K inhibitors PX-866 and BAY80-6946, the senolytic compound Navitoclax, and the pan-kinase inhibitor staurosporine (3 µM) as a positive control. After 24 h, LDH activity in the cell culture supernatant as a marker for cell death was determined. The data shown are the mean ± SD of at least three independent experiments. Individual data points are represented in the bar charts by small black squares. Significance indicators relate to the corresponding control (proliferating/senescent) treated with DMSO. *p < 0.05, **p < 0.01, ***p < 0.001. less

Collected and cropped from Cell Death & Disease by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

In Cell Death Dis on 29 May 2024 by Neuwahl, J., Neumann, C. A., et al.

Fig.6.C

Fig.6.C showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µ... more

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µM) for another 24 h. Cell death was assessed by quantifying LDH activity released into the cell culture supernatant (B), whereas inhibition of AKT phosphorylation and the knockdown of p53 or p21 protein expression was verified by western blotting (A). C–F Senescent (day 7 after γIR) HCT116 (C, D) or MCF-7 (E, F) cells were treated with either 3 µM PX-866, 10 µM MG-132 or a combination of both. At the indicated times, the cells were harvested and the cell extracts subjected to western blot analysis (C, E). The blots shown are representative of at least three independent experiments. The expression of p21 was quantified densitometrically using the Image Studio (Ver. 5.2) software (LI-COR). Relative p21 levels normalized to the no treatment sample (also indicated by a gray line) were plotted (D, F). Data shown are the mean ± SD of at least three independent experiments. Individual data points are represented in the bar charts by small black squares. ns not significant *p < 0.05, **p < 0.01, ***p < 0.001. less

Collected and cropped from Cell Death & Disease by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

In Cell Death Dis on 29 May 2024 by Neuwahl, J., Neumann, C. A., et al.

Fig.6.A

Fig.6.A showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µ... more

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µM) for another 24 h. Cell death was assessed by quantifying LDH activity released into the cell culture supernatant (B), whereas inhibition of AKT phosphorylation and the knockdown of p53 or p21 protein expression was verified by western blotting (A). C–F Senescent (day 7 after γIR) HCT116 (C, D) or MCF-7 (E, F) cells were treated with either 3 µM PX-866, 10 µM MG-132 or a combination of both. At the indicated times, the cells were harvested and the cell extracts subjected to western blot analysis (C, E). The blots shown are representative of at least three independent experiments. The expression of p21 was quantified densitometrically using the Image Studio (Ver. 5.2) software (LI-COR). Relative p21 levels normalized to the no treatment sample (also indicated by a gray line) were plotted (D, F). Data shown are the mean ± SD of at least three independent experiments. Individual data points are represented in the bar charts by small black squares. ns not significant *p < 0.05, **p < 0.01, ***p < 0.001. less

Collected and cropped from Cell Death & Disease by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

In Cell Death Dis on 29 May 2024 by Neuwahl, J., Neumann, C. A., et al.

Fig.6.E

Fig.6.E showing Western Blotting from the publication: Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells.

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µ... more

PX-866 induces proteasomal degradation of p21 in senescent cells.A, B Proliferating and senescent (day 7 after γIR) HCT116 cells were transfected with a non-targeting control siRNA or siRNAs directed against p53 or p21. 48 h after transfection, the cells were additionally treated with PX-866 (3 µM) for another 24 h. Cell death was assessed by quantifying LDH activity released into the cell culture supernatant (B), whereas inhibition of AKT phosphorylation and the knockdown of p53 or p21 protein expression was verified by western blotting (A). C–F Senescent (day 7 after γIR) HCT116 (C, D) or MCF-7 (E, F) cells were treated with either 3 µM PX-866, 10 µM MG-132 or a combination of both. At the indicated times, the cells were harvested and the cell extracts subjected to western blot analysis (C, E). The blots shown are representative of at least three independent experiments. The expression of p21 was quantified densitometrically using the Image Studio (Ver. 5.2) software (LI-COR). Relative p21 levels normalized to the no treatment sample (also indicated by a gray line) were plotted (D, F). Data shown are the mean ± SD of at least three independent experiments. Individual data points are represented in the bar charts by small black squares. ns not significant *p < 0.05, **p < 0.01, ***p < 0.001. less

Collected and cropped from Cell Death & Disease by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

In Commun Biol on 31 October 2022 by Ludikhuize, M. C., Gevers, S., et al.

Fig.3.A

Fig.3.A showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western bl... more

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western blot detection of p53, p21, (p)Rb and vinculin in WT and CRC organoids treated with 5-FU for 48 h (representative for n = 4). WT, AK, AP, APK, APKS were run together on the same gels. c Cell cycle profile determined by flow cytometry in WT and CRC organoids treated with 5-FU for 48 h (mean ± SEM, n = 4 (WT), 3 (AK), 5 (AP), 7 (APK), 6 (APKS), Kruskal–Wallis test, unpaired t-test and Mann–Whitney test). d Western blot analysis of γH2AX and tubulin of AP, APK and APKS organoids treated with 5-FU for 48 h. Palbociclib treatment was started 24 h before 5-FU treatment to arrest cells in G1 (representative for n = 3). AP, APK, and APKS were run together on the same gels. e, f Representative brightfield imaging (e) and cell viability analysis (f) of AP, APK, and APKS organoids treated with 5-FU for 6 days. Palbociclib treatment started 24 h before 5-FU treatment to arrest cells in G1 (scale bar = 500 µm, mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). g Western blot detection of p53, p21, γH2AX, and β-actin in doxycycline-inducible APK-P53OE and APKS -P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (representative for n = 3). APK and APKS were run on separate gels. h Cell cycle profiles of doxycycline-inducible APK-P53OE and APKS-P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). i, j Brightfield images (i) and cell viability analysis (j) of doxycycline-inducible APK-P53OE and APKS-P53OE organoids by flow cytometry to distinguish alive (DAPI−) from dead (DAPI+) cells upon 4 days of 5-FU treatment. APK: doxycycline (40 ng/ml) treatment was started 16 h before and washed away 24 h after 5-FU administration. APKS: doxycycline (200 ng/ml) treatment was started 16 h before 5-FU administration and was not washed away (scale bar = 500 µm, mean ± SEM, n = 6 (APK-P53 OE), 4 (APKS-P53 OE), one-way ANOVA, Sidak’s multiple comparisons test). ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. less

Collected and cropped from Communications Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

In Commun Biol on 31 October 2022 by Ludikhuize, M. C., Gevers, S., et al.

Fig.3.B

Fig.3.B showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western bl... more

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western blot detection of p53, p21, (p)Rb and vinculin in WT and CRC organoids treated with 5-FU for 48 h (representative for n = 4). WT, AK, AP, APK, APKS were run together on the same gels. c Cell cycle profile determined by flow cytometry in WT and CRC organoids treated with 5-FU for 48 h (mean ± SEM, n = 4 (WT), 3 (AK), 5 (AP), 7 (APK), 6 (APKS), Kruskal–Wallis test, unpaired t-test and Mann–Whitney test). d Western blot analysis of γH2AX and tubulin of AP, APK and APKS organoids treated with 5-FU for 48 h. Palbociclib treatment was started 24 h before 5-FU treatment to arrest cells in G1 (representative for n = 3). AP, APK, and APKS were run together on the same gels. e, f Representative brightfield imaging (e) and cell viability analysis (f) of AP, APK, and APKS organoids treated with 5-FU for 6 days. Palbociclib treatment started 24 h before 5-FU treatment to arrest cells in G1 (scale bar = 500 µm, mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). g Western blot detection of p53, p21, γH2AX, and β-actin in doxycycline-inducible APK-P53OE and APKS -P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (representative for n = 3). APK and APKS were run on separate gels. h Cell cycle profiles of doxycycline-inducible APK-P53OE and APKS-P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). i, j Brightfield images (i) and cell viability analysis (j) of doxycycline-inducible APK-P53OE and APKS-P53OE organoids by flow cytometry to distinguish alive (DAPI−) from dead (DAPI+) cells upon 4 days of 5-FU treatment. APK: doxycycline (40 ng/ml) treatment was started 16 h before and washed away 24 h after 5-FU administration. APKS: doxycycline (200 ng/ml) treatment was started 16 h before 5-FU administration and was not washed away (scale bar = 500 µm, mean ± SEM, n = 6 (APK-P53 OE), 4 (APKS-P53 OE), one-way ANOVA, Sidak’s multiple comparisons test). ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. less

Collected and cropped from Communications Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

In Commun Biol on 31 October 2022 by Ludikhuize, M. C., Gevers, S., et al.

Fig.4.A

Fig.4.A showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in PDOs.a Western blot detection of p53, p21 and tubulin in WT and P9t, P16t and P19bt organoids treated with 5-FU for 48 h (representative for n = 3). WT, P9t, P16t and P19bt were run together on the same g... more

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in PDOs.a Western blot detection of p53, p21 and tubulin in WT and P9t, P16t and P19bt organoids treated with 5-FU for 48 h (representative for n = 3). WT, P9t, P16t and P19bt were run together on the same gels. b Quantification of cells with DNA damage by flow cytometry of P9t, P16t and P19bt organoids treated with 5-FU for 48 h and stained with anti-γH2AX (mean ± SEM, n = 6 (P9t), 3 (P16t), 4 (P19bt), one-way ANOVA, Sidak’s multiple comparisons test). c Cell cycle profile analysis by flow cytometry of P9t, P16t, and P19bt organoids treated with 5-FU for 48 h and stained with DAPI (mean ± SEM, n = 6 (P9t), 3 (P16t), 4 (P19bt) 4, P9t and P16t: unpaired t-test, P19bt: Mann–Whitney test). d, e Brightfield images (d) and cell viablility analysis (e) of P9t, P16t, and P19bt organoids treated with 5-FU for 6 days (scale bar = 500 µm, mean ± SEM, n = 5 (P9t), 8 (P16t), 4 (P19bt) 4, one-way ANOVA, Sidak’s multiple comparisons test). f, g Western blot detection of p53, p21, γH2AX, and β-actin (f) and cell cycle profile analysis (g) in doxycycline-inducible P16t-P53OE and P19bt-P53OE organoids treated with 5-FU for 48 h. Doxycycline treatment (200 ng/ml) was started 16 h before and washed away 24 h after 5-FU administration (representative for n = 3, mean ± SEM, n = 4 (P16t-P53OE), 3 (P19bt-P53OE), one-way ANOVA, Sidak’s multiple comparisons test). P16t-P53OE and P19bt-P53OE were run together on the same gels. h, i Bright field images (h) and cell viability analysis (i) of doxycycline-inducible P16t-P53OE and P19bt-P53OE organoids treated with 5-FU for 6 days. Doxycycline treatment (200 ng/ml) was started 16 h before and washed away 24 h after 5-FU administration (scale bar = 500 µm, mean ± SEM, n = 5, one-way ANOVA, Sidak’s multiple comparisons test). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. less

Collected and cropped from Communications Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

In Commun Biol on 31 October 2022 by Ludikhuize, M. C., Gevers, S., et al.

Fig.4.F

Fig.4.F showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in PDOs.a Western blot detection of p53, p21 and tubulin in WT and P9t, P16t and P19bt organoids treated with 5-FU for 48 h (representative for n = 3). WT, P9t, P16t and P19bt were run together on the same g... more

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in PDOs.a Western blot detection of p53, p21 and tubulin in WT and P9t, P16t and P19bt organoids treated with 5-FU for 48 h (representative for n = 3). WT, P9t, P16t and P19bt were run together on the same gels. b Quantification of cells with DNA damage by flow cytometry of P9t, P16t and P19bt organoids treated with 5-FU for 48 h and stained with anti-γH2AX (mean ± SEM, n = 6 (P9t), 3 (P16t), 4 (P19bt), one-way ANOVA, Sidak’s multiple comparisons test). c Cell cycle profile analysis by flow cytometry of P9t, P16t, and P19bt organoids treated with 5-FU for 48 h and stained with DAPI (mean ± SEM, n = 6 (P9t), 3 (P16t), 4 (P19bt) 4, P9t and P16t: unpaired t-test, P19bt: Mann–Whitney test). d, e Brightfield images (d) and cell viablility analysis (e) of P9t, P16t, and P19bt organoids treated with 5-FU for 6 days (scale bar = 500 µm, mean ± SEM, n = 5 (P9t), 8 (P16t), 4 (P19bt) 4, one-way ANOVA, Sidak’s multiple comparisons test). f, g Western blot detection of p53, p21, γH2AX, and β-actin (f) and cell cycle profile analysis (g) in doxycycline-inducible P16t-P53OE and P19bt-P53OE organoids treated with 5-FU for 48 h. Doxycycline treatment (200 ng/ml) was started 16 h before and washed away 24 h after 5-FU administration (representative for n = 3, mean ± SEM, n = 4 (P16t-P53OE), 3 (P19bt-P53OE), one-way ANOVA, Sidak’s multiple comparisons test). P16t-P53OE and P19bt-P53OE were run together on the same gels. h, i Bright field images (h) and cell viability analysis (i) of doxycycline-inducible P16t-P53OE and P19bt-P53OE organoids treated with 5-FU for 6 days. Doxycycline treatment (200 ng/ml) was started 16 h before and washed away 24 h after 5-FU administration (scale bar = 500 µm, mean ± SEM, n = 5, one-way ANOVA, Sidak’s multiple comparisons test). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. less

Collected and cropped from Communications Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

In Commun Biol on 31 October 2022 by Ludikhuize, M. C., Gevers, S., et al.

Fig.3.G

Fig.3.G showing Western Blotting from the publication: Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors.

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western bl... more

Inactive p53 leads to 5-FU-induced DNA damage and cell death due to the lack of G1 arrest in TPOs.a Western blot detection of p53, p21 and vinculin in WT and AK organoids treated with 5-FU for 4, 8, 16, 24, and 48 h (blot representative for n = 4). WT and AK were run on the same gel. b Western blot detection of p53, p21, (p)Rb and vinculin in WT and CRC organoids treated with 5-FU for 48 h (representative for n = 4). WT, AK, AP, APK, APKS were run together on the same gels. c Cell cycle profile determined by flow cytometry in WT and CRC organoids treated with 5-FU for 48 h (mean ± SEM, n = 4 (WT), 3 (AK), 5 (AP), 7 (APK), 6 (APKS), Kruskal–Wallis test, unpaired t-test and Mann–Whitney test). d Western blot analysis of γH2AX and tubulin of AP, APK and APKS organoids treated with 5-FU for 48 h. Palbociclib treatment was started 24 h before 5-FU treatment to arrest cells in G1 (representative for n = 3). AP, APK, and APKS were run together on the same gels. e, f Representative brightfield imaging (e) and cell viability analysis (f) of AP, APK, and APKS organoids treated with 5-FU for 6 days. Palbociclib treatment started 24 h before 5-FU treatment to arrest cells in G1 (scale bar = 500 µm, mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). g Western blot detection of p53, p21, γH2AX, and β-actin in doxycycline-inducible APK-P53OE and APKS -P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (representative for n = 3). APK and APKS were run on separate gels. h Cell cycle profiles of doxycycline-inducible APK-P53OE and APKS-P53OE organoids treated with 5-FU for 48 h (doxycycline (40 ng/ml for APK and 200 ng/ml for APKS) treatment was started 16 h before 5-FU administration) (mean ± SEM, n = 3, one-way ANOVA, Sidak’s multiple comparisons test). i, j Brightfield images (i) and cell viability analysis (j) of doxycycline-inducible APK-P53OE and APKS-P53OE organoids by flow cytometry to distinguish alive (DAPI−) from dead (DAPI+) cells upon 4 days of 5-FU treatment. APK: doxycycline (40 ng/ml) treatment was started 16 h before and washed away 24 h after 5-FU administration. APKS: doxycycline (200 ng/ml) treatment was started 16 h before 5-FU administration and was not washed away (scale bar = 500 µm, mean ± SEM, n = 6 (APK-P53 OE), 4 (APKS-P53 OE), one-way ANOVA, Sidak’s multiple comparisons test). ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. less

Collected and cropped from Communications Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.

In BMC Mol Cell Biol on 14 July 2022 by Yuan, C. H., Hsu, W. C., et al.

Fig.5.A

Fig.5.A showing Western Blotting in a Homo sapiens (Human) sample from the publication: MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.

MiR-145-5p and KLF5 modulates phospho-FAKTyr397 expression in nasopharyngeal carcinoma (NPC) cells. a MiR-145-5p induced p21 and reduced cyclin D1, cyclin B1, pro-caspase 3 and PARP protein expression post-transfection with scramble control or miR-145-5p mimics in NPC-TW03 and NPC-TW04 cells, wer... more

MiR-145-5p and KLF5 modulates phospho-FAKTyr397 expression in nasopharyngeal carcinoma (NPC) cells. a MiR-145-5p induced p21 and reduced cyclin D1, cyclin B1, pro-caspase 3 and PARP protein expression post-transfection with scramble control or miR-145-5p mimics in NPC-TW03 and NPC-TW04 cells, were probes with anti cyclin D1, cyclin B1, p21, pro-caspase 3, PARP and specific antibodies for each compartments corresponding to anti α-tubulin. b MiR-145-5p down-regulates phospho-FAKTyr397 protein expression post-transfection with scramble control or miR-145-5p mimics in NPC-TW03 and NPC-TW04 cells, were probes with anti phospho-FAKTyr397, FAK and specific antibodies for each compartments corresponding to anti β-actin. c Quantification of phospho-FAKTyr397/FAK expression are the average of three independent experiments, using the Image J software and β-actin as a reference. d Western blot analysis indicating phospho-FAKTyr397 and FAK expression in NPC-TW03 and NPC-TW04 cells post-transfection with CMV or CMV-KLF5 vectors, were probes with anti phospho-FAKTyr397, FAK and specific antibodies for each compartments corresponding to anti β-actin. e Quantification of phospho-FAKTyr397/FAK expression are the average of three independent experiments, using the Image J software and β-actin as a reference. f The possible molecular network between KLF5 and FAK was analyzed by Ingenuity Pathway Analysis. g PROMO tool identified the putative transcription factor binding sites in FAK DNA sequences. Data are shown as mean ± SD from three independent experiments. *P < 0.05, **P < 0.01, respectively less

Collected and cropped from BMC Molecular and Cell Biology by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Mithramycin selectively attenuates DNA-damage-induced neuronal cell death.

In Cell Death Dis on 27 July 2020 by Makarevich, O., Sabirzhanov, B., et al.

Fig.2.A

Fig.2.A showing Western Blotting from the publication: Mithramycin selectively attenuates DNA-damage-induced neuronal cell death.

Mithramycin attenuates etoposide-induced apoptotic pathways downstream of p53 activation.a, c RCN were treated with 50µM etoposide +/−200 nM mithramycin. After 3, 6, 16, or 24 h, cells were harvested. Equal amounts of whole-cell lysates were loaded onto an SDS-polyacrylamide gel and after electro... more

Mithramycin attenuates etoposide-induced apoptotic pathways downstream of p53 activation.a, c RCN were treated with 50µM etoposide +/−200 nM mithramycin. After 3, 6, 16, or 24 h, cells were harvested. Equal amounts of whole-cell lysates were loaded onto an SDS-polyacrylamide gel and after electrophoretic separation and transfer to a membrane were incubated with antibodies against DNA-damage markers: phospho-ATM (S1981) and γH2AX, or phospho-p53 (S15) and its downstream targets: PUMA and p21 (a). Other membranes were incubated with antibodies against cleaved/activated caspase-3 (Casp3) and caspase-7 (Casp7), their substrates α-Fodrin and cleaved PARP, as well as PSD95 (c). Protein levels (of bands indicated by arrows) were quantified by densitometry, normalized to appropriate β-actin signal and are presented as normalized fold change compared with control levels. Representative actin blots are shown here. n = 3/group for all groups. Data represent mean ±SD. Significance assigned based on one-way ANOVA and Tukey post hoc test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs control; ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 vs etoposide alone. b Phospho-p53 (S15) levels were also analyzed by immunocytochemistry after 6h. A representative set of × 63 images is shown here, white arrows indicate sample neuron co-localized with ph-p53 (S15). Quantification of cells was done across at least 6 fields per treatment. Data are presented as an unbinned cumulative frequency distribution. Significance assigned based on Kruskal–Wallis test followed by Dunn’s post hoc analysis; ****p < 0.0001 vs control. less

Collected and cropped from Cell Death & Disease by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70

Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.

In Int J Mol Sci on 23 July 2020 by Borkham-Kamphorst, E., Haas, U., et al.

Fig.4.C

Fig.4.C showing Western Blotting in a Mus musculus (House mouse) sample from the publication: Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.

Lcn2−/− hepatocytes reflecting strongest ER stress responses. (A) Real-time quantitative polymerase chain reaction (RT-qPCR) showing Lcn2 mRNA and ER stress-markers Bip/Grp78, Grp94, Chop, and Creb3L3 upon 24 h incubation with IL-1β, tunicamycin (TM), and thapsigargin (TG). IL-1β significantly in... more

Lcn2−/− hepatocytes reflecting strongest ER stress responses. (A) Real-time quantitative polymerase chain reaction (RT-qPCR) showing Lcn2 mRNA and ER stress-markers Bip/Grp78, Grp94, Chop, and Creb3L3 upon 24 h incubation with IL-1β, tunicamycin (TM), and thapsigargin (TG). IL-1β significantly induced Lcn2 mRNA expression, while Bip/Grp78, Grp94, and Chop mRNA levels were also markedly increased by TM or TG stimulation, while Lcn2−/− hepatocytes showed the highest levels. Additionally, the Lcn2−/− hepatocytes possessed already high basal levels of Creb3L3. Details about the statistics are given in Supplementary Table S6. (B) Semi-quantitative PCR depicting unspliced (Xbp1u) and spliced Xbp1 (Xbp1s) mRNA. Lcn2−/− hepatocytes incubated with TM showing the most significant amounts of Xbp1s. (C) Western blot analysis of ER stress marker proteins GRP94, BiP, IRE1α, ATF6, GADD34, p-eIF2α, eIF2α, ATF4, and CHOP with β-actin as loading controls. Lcn2−/− hepatocytes showed the highest ER stress responses with huge amounts of CHOP, while Chop−/− hepatocytes increased higher baselines of p-eIF2α with decreased GADD34 and other UPR signaling proteins. (D) TM-induced ER stress was showed to activate and cleave CREB3L3/CREBH. TM activated NF-κB p65, TRAF2/JNK/c-Jun, and further inhibited LCN2 glycosylation, as evidenced by shifting of the LCN2 molecular weight, with GAPDH as loading controls. (E) TM altered expression of Bcl2 family proteins, Lcn2−/− hepatocytes were clearly demonstrated to decrease Bcl-xL, and increase Bax, Bak, and PUMA with higher Cytochrome c levels. GAPDH was applied as loading control. less

Collected and cropped from International Journal of Molecular Sciences by CiteAb, provided under a CC-BY license

View on PubMed®

Image 1 of 70